Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06792890 · ClinicalTrials.gov registry record · NA
A Randomized Controlled Trial of Ambient Artificial Intelligence Scribe Technologies
A NA study of Artificial Intelligence (AI) and Physician Workflow, sponsored by University of California, Los Angeles.
- Active
- Registry status
- NA
- Development phase
- 238
- Enrollment target
- 1
- Study location
NCT06792890 is a NA study of Artificial Intelligence (AI) and Physician Workflow that is active but no longer recruiting, run by University of California, Los Angeles. The registered enrollment target is 238 participants, below the 133,423-participant average among 3 other Artificial Intelligence (AI) trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06792890, a NA study of Artificial Intelligence (AI) and Physician Workflow, is active but no longer recruiting, sponsored by University of California, Los Angeles.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 238 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a three-arm pragmatic RCT of 238 outpatient physicians at a large academic health system, randomized 1:1:1 to one of two AI scribe tools or a usual-care control group. The two-month study will observe and compare the effects of each tool prior to system-wide roll out of selected tool (anticipated Spring 2025). We will use covariate-constrained randomization to balance the arms in terms of physician baseline time in notes, survey-measured level of burnout, and clinic days per week. The primary purpose of the initiative is to improve quality, efficiency, and business operations at University of California, Los Angeles (UCLA) Health, and this initiative is not being done for research purposes. The results of this operational initiative will inform the widespread roll out of AI scribe tools across all providers within the UCLA Health System. Nevertheless, the UCLA study team plans to rigorously examine and publish the impact of this intervention across the health system, which is why the study team pre-registered the initiative.
Conditions Studied
Interventions
- OTHER Use Nabla AI Scribe tool provided
- OTHER Use AI Scribe tool provided by Vendor B
Study Locations (1)
California
- UCLA Health System - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 238 participants |
| Start Date | 2024-11-04 |
| Est. Completion | 2025-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06792890
The ClinicalTrials.gov registry entry for NCT06792890 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 238 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 133,423-participant average among 3 other Artificial Intelligence (AI) trials with a reported enrollment target (100% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Artificial Intelligence (AI) appearing as the primary indexed condition, and to 2 interventions - of which Use Nabla AI Scribe tool provided is the first listed.
NCT06792890 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06792890 about?
NCT06792890 is a clinical study titled "A Randomized Controlled Trial of Ambient Artificial Intelligence Scribe Technologies". This is a three-arm pragmatic RCT of 238 outpatient physicians at a large academic health system, randomized 1:1:1 to one of two AI scribe tools or a usual-care control group. The two-month study will observe and compare the effects of each tool prior to system-wide roll out of selected tool (antici...
What is the current status of trial NCT06792890?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 238 participants. The study started on 2024-11-04. Estimated completion is 2025-02-28.
What conditions does trial NCT06792890 study?
This clinical trial studies the following conditions: Artificial Intelligence (AI), Physician Workflow.
What interventions are being tested in trial NCT06792890?
The interventions under investigation include: Use Nabla AI Scribe tool provided (OTHER), Use AI Scribe tool provided by Vendor B (OTHER).
Who is sponsoring clinical trial NCT06792890?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06792890 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Artificial Intelligence (AI)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impact of Artificial Intelligence on Trainee Polyp Miss Rates
RECRUITING · NA
-
Structured Handoff Using Intelligent Framework for Transitions Trial
RECRUITING · NA
-
A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients
RECRUITING · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.